Acute otitis media in children. Are antibiotics always appropriate?

C Del Mar1, P Glasziou

  • 1Centre for General Practice, Graduate School of Medicine, University of Queensland.

Insights

Antibiotics for acute otitis media in children benefit only 1 in 20 by reducing short-term pain. There is no clear benefit for hearing, recurrent infections, or complications, suggesting less frequent antibiotic use.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Evidence-Based Medicine

Background:

  • Acute otitis media (AOM) is a common childhood infection in Western countries.
  • Antibiotic therapy is frequently prescribed for AOM.
  • The overall benefit of routine antibiotic use for AOM requires further evaluation.

Purpose of the Study:

  • To evaluate the efficacy of antibiotics as an initial treatment for acute otitis media in children.
  • To determine the benefits of antibiotic treatment on pain, deafness, recurrent attacks, and complications of AOM.

Main Methods:

  • Systematic analysis of existing evidence on antibiotic treatment for pediatric AOM.
  • Assessment of outcomes including pain reduction, hearing impairment, recurrence rates, and complications.

Main Results:

  • Antibiotics benefit approximately 5% (1 in 20) of children by alleviating acute pain.
  • No significant benefits were observed for deafness, recurrent AOM episodes, or severe complications.
  • The evidence does not support widespread antibiotic use for AOM.

Conclusions:

  • The marginal benefit of antibiotics for AOM pain does not outweigh the risks and costs associated with their use.
  • A more judicious approach to antibiotic prescribing for pediatric AOM is recommended.
  • Future research should focus on non-antibiotic management strategies and antibiotic stewardship.

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...